JG
NMTR

Jefferies Group’s 9 Meters Biopharma NMTR Stock Holding History

Jefferies Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,916
Closed -$162K – 2099
2021
Q1 		$162K Buy
+6,916
New +$213K ﹤0.01% 1390
2018
Q4 		– Sell
-4,935
Closed -$674K – 2696
2018
Q3 		$674K Buy
+4,935
New +$848K ﹤0.01% 1507

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jefferies Group's NMTR Position: Q2 2021 in Review

Jefferies Group sold out of 9 Meters Biopharma (NMTR) in Q2 2021, closing a stake of 6,916 shares — an estimated $162K sold.

Jefferies Group first reported a position in NMTR in Q3 2018 and held it in 2 quarters. The position peaked at $674K in Q3 2018. 99 funds tracked by Wall St. Rank hold NMTR as of Q2 2021.

  • Jefferies Group reported no remaining 9 Meters Biopharma position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 6,916 9 Meters Biopharma shares in Q2 2021, an estimated $162K.
  • Jefferies Group first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 2 quarters.
  • Jefferies Group's 9 Meters Biopharma position peaked at $674K in Q3 2018.
  • 99 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.